EG ·
IRBEVASC PLUS 300\12.5 MG 7 TAB
IRBEVASC PLUS 300\12.5 MG 7 TAB
Composition
These source-reported data require scientific review and are not treatment advice.
HYDROCHLOROTHIAZIDE
· AMOUNT_PER_UNIT
IRBESARTAN
· AMOUNT_PER_UNIT
Registration
Packages and prices
IRBEVASC PLUS 300 12.5 MG 7 TABLETS
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| COAPROVEL 150\12.5 MG 14 TAB | SAME_ACTIVE_INGREDIENT_SET | route | — EGP |
| CO APROVEL 300MG/12.5MG 14/TAB | SAME_ACTIVE_INGREDIENT_SET | route | — EGP |
| COAPROVEL 150\12.5MG 28/TAB | SAME_ACTIVE_INGREDIENT_SET | route | — EGP |
| X-TENSION PLUS 150/12.5 MG 28 TAB | SAME_ACTIVE_INGREDIENT_SET | route | — EGP |
| Irbezide 10tab | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| ATACAND PLUS 16/12.5MG 14TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| SPIROZIDE 20/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| HYZAAR 50/12.5 MG 14 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| REMTOZAR-D 10TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| HYDRETIC 12.5mg10/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| IRBEDRIN 300 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| ALBUSTIX D 16/12.5 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |